SEC Comment Letter for ANGIOTECH PHARMACEUTICALS INC (CIK 0001096481) — Nov 16, 2005
ANGIOTECH PHARMACEUTICALS INC (CIK 0001096481)
Date: Nov. 16, 2005 · CIK: 0001096481 · Accession: 0000000000-05-058067
AI Filing Summary & Sentiment
File numbers found in text: 000-30334
Letter
Via Facsimile and U.S. Mail Mail Stop 6010 November 16, 2005 Mr. David M. Hall Chief Financial Officer Angiotech Pharmaceuticals, Inc. 1618 Station Street Vancouver, B.C. V6A 1B6 CANADA
Re: Angiotech Pharmaceuticals, Inc. Form 40-F for Fiscal Year Ended December 31, 2004 Filed April 1, 2005 File No. 000-30334
Dear Mr. Hall:
We have completed our review of your Form 40-F and have no further comments at this time.
Sincerely,
Jim Atkinson
Accounting Branch Chief
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Via Facsimile and U.S. Mail
Mail Stop 6010
November 16, 2005
Mr. David M. Hall
Chief Financial Officer
Angiotech Pharmaceuticals, Inc.
1618 Station Street
Vancouver, B.C. V6A 1B6
CANADA
Re: Angiotech Pharmaceuticals, Inc.
Form 40-F for Fiscal Year Ended December 31, 2004
Filed April 1, 2005
File No. 000-30334
Dear Mr. Hall:
We have completed our review of your Form 40-F and have no
further comments at this time.
Sincerely,
Jim Atkinson
Accounting Branch Chief
??
??
??
??
</TEXT>
</DOCUMENT>